Bluebird Bio (BLUE) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -61.9 | -24.3 | -0.87 | -0.65 | -2.40 | -1.36 | ||
| Changes by years, y/y, % | -22% | -61% | -96% | -25% | +270% | -50.4% | |||
Bluebird Bio. EV/EBITDA
Bluebird Bio. EV/EBITDA, changes, %
Bluebird Bio (BLUE) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | LTM ? | |||
| EV/EBITDA | ? | -0.41 | -0.93 | -4.43 | -5.27 | -1.36 | -1.36 | |
| Changes by years, y/y, % | +14% | -98% | +235% | +1 188% | ||||
| Changes by quarters, q/q, % | -46% | +127% | +378% | +19% | -74% | |||